GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Axonics Inc (MEX:AXNX) » Definitions » Other Stockholders Equity

Axonics (MEX:AXNX) Other Stockholders Equity : MXN-0 Mil (As of Jun. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Axonics Other Stockholders Equity?

Axonics's Other Stockholders Equity for the quarter that ended in Jun. 2024 was MXN-0 Mil.

Axonics's quarterly Other Stockholders Equity increased from Dec. 2023 (MXN-0 Mil) to Mar. 2024 (MXN0 Mil) but then declined from Mar. 2024 (MXN0 Mil) to Jun. 2024 (MXN-0 Mil).

Axonics's annual Other Stockholders Equity increased from Dec. 2021 (MXN0 Mil) to Dec. 2022 (MXN0 Mil) but then declined from Dec. 2022 (MXN0 Mil) to Dec. 2023 (MXN-0 Mil).


Axonics Other Stockholders Equity Historical Data

The historical data trend for Axonics's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Axonics Other Stockholders Equity Chart

Axonics Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Stockholders Equity
Get a 7-Day Free Trial - - - - -

Axonics Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Axonics Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity


Axonics Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Axonics's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Axonics Business Description

Traded in Other Exchanges
Address
26 Technology Drive, Irvine, CA, USA, 92618
Axonics Inc is a United States-based medical technology company. It focuses on developing and commercializing novel products for adults with bladder and bowel dysfunction, that include implantable SNM systems to treat urinary urge incontinence and urinary urgency frequency (UUF); a urethral bulking agent (Bulkamid) to treat female stress urinary incontinence. SNM therapy is predominantly used to treat patients with overactive bladder, fecal incontinence, and urinary retention. Geographically, the company generates majority of its revenue from United States and rest from International markets.